Technology
Health
Pharmaceutical

Takeda Pharmaceutical

$18.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-0.69%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell TAK and other stocks, options, ETFs, and crypto commission-free!

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. Read More The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

CEO
Christophe Weber
Employees
47,495
Headquarters
Osaka, Osaka
Founded
1781
Market Cap
58.49B
Price-Earnings Ratio
59.04
Dividend Yield
—
Average Volume
1.11M
High Today
$18.99
Low Today
$18.66
Open Price
$18.96
Volume
3.37M
52 Week High
$20.93
52 Week Low
$12.43

Collections

Technology
Health
Pharmaceutical
Healthcare
Research And Development
Advertising and Marketing
Medical
Business Services

TAK News

ReutersSep 17

Takeda-led COVID-19 plasma product to begin trial this month

TOKYO, Sept 17 (Reuters) - An experimental COVID-19 therapy using blood plasma, developed by Japan’s Takeda Pharmaceutical Co and its partners, is scheduled to

TAK Earnings

$0.00
$0.39
$0.79
$1.18
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Oct 29, Pre-Market

You May Also Like

AACQW
MUFG
ALEC
PNR
AERI
WFC-Y
HPE
FXD
GIGB
ALXN
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Buy TAK
Market Price
$18.71
Commissions
$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell TAK stock and options commission-free.
LearnBlogCareersHelpLog InSign Up